Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine with different NSAIDs for postoperative analgesia after laparoscopic cholecystectomy
ChiCTR2600123963Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tizanidine, parecoxib and flurbiprofen axetil in postoperative pain (4 arms), sponsored by Shanghai East Hospital. Primary endpoint: 24h composite benefit endpoint success rate. Planned start May 2026; status: not yet recruiting.
02
Drugs
tizanidineparecoxibflurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600123963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123963.